Literature DB >> 3361155

Specific antibodies detected during relapse of human brucellosis.

T Pellicer1, J Ariza, A Foz, R Pallares, F Gudiol.   

Abstract

We studied 10 patients who had a relapse of brucellosis for significant serological changes during relapse. By the Coombs test, the pre-relapse and post-relapse median (range) titers of antibody to Brucella were 1:1120 (1:40-1:10,240) and 1:10,240 (1:40-1:81,920), respectively (P = .0069); by enzyme-linked immunosorbent assay (ELISA) for IgG, these values were 1:2240 (1:60-1:10,240) and 1:10,240 (1:160-1:81,920; P = .0069); by ELISA for IgA, the median titer increased 3.36 times but did not reach statistical significance (P = .0929); by tube agglutination, dithiothreitol (DTT) agglutination, and ELISA for IgM, median titers did not change. Nine patients had a significant titer increase by Coombs test and IgG ELISA, three had a significant increase by tube and DTT agglutination, none had significant increases by IgM ELISA, and one had no significant increase after relapse. Our findings show that for most patients with a relapse of brucellosis, there is an increase in IgG titers, as detected by ELISA and Coombs test, but no change in IgM titers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361155     DOI: 10.1093/infdis/157.5.918

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Posttreatment follow-Up of brucellosis by PCR assay.

Authors:  P Morata; M I Queipo-Ortuño; J M Reguera; M A García-Ordoñez; C Pichardo; J D Colmenero
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.

Authors:  R A Bowden; G C Racaro; P C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis.

Authors:  R Díaz; J Ariza; I Alberola; A Casanova; M F Rubio
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

4.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

5.  Specific IgE response in patients with brucellosis.

Authors:  G F Araj; A R Lulu; M I Khateeb; M Haj
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

6.  Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses.

Authors:  F A Goldbaum; C P Rubbi; J C Wallach; S E Miguel; P C Baldi; C A Fossati
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 7.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

8.  Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis.

Authors:  Encarnación Clavijo; Ramón Díaz; Angel Anguita; Antonio García; Alfonso Pinedo; Henk L Smits
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis.

Authors:  Henk L Smits; Theresia H Abdoel; Javier Solera; Encarnacion Clavijo; Ramon Diaz
Journal:  Clin Diagn Lab Immunol       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.